Clinical Trials Logo

Graves Disease clinical trials

View clinical trials related to Graves Disease.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06418919 Active, not recruiting - Clinical trials for Thyroid; Functional Disturbance

A Prospective Evaluation of Radiofrequency Ablation in the Treatment of Relapsed Graves' Disease.

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

There have been previous reports of using High-intensity focused ultrasound (HIFU) as a feasible thermal ablative treatment for relapsed Graves' disease. In recent years, radiofrequency ablation (RFA) has become another promising alternative for thermal ablation of benign thyroid nodules. RFA has the advantage of avoiding a surgical scar, organ preservation and being an ambulatory procedure. It utilizes a small caliber radiofrequency electrode, which is inserted into the thyroid gland percutaneously. The active tip of the RF electrode would induce frictional heat in the surrounding tissue, causing a thermal ablative effect. The direct application of energy of RFA to tissue is different from that in HIFU, in which energy is transmitted through the skin of the participants from the transducer. Studies of follow-up after RFA of Graves' disease have not been published. Given the previous successful experience with HIFU, the investigators would like to explore the feasibility, safety and efficacy of RFA as an alternative thermal ablation option for relapsed Graves' disease. Thus, the purpose of this prospective study is to assess the efficacy and safety of US-guided RFA for the treatment of relapsed Graves' disease.

NCT ID: NCT04333342 Active, not recruiting - Clinical trials for Graves' Disease in Remission (Disorder)

Heart Rate Monitoring by Wearable Devices in Graves' Disease

Start date: November 22, 2019
Phase: N/A
Study type: Interventional

A multi center randomized controlled study including 3 arms (wearable device group, control group 1, control group 2). This study is to investigate clinical feasibility of heart rate monitoring using wearable devices to detect disease recurrence in the patients who discontinue anti-thyroid drugs in remission state.

NCT ID: NCT04135573 Active, not recruiting - Graves Disease Clinical Trials

The Relationship Between NK Cell and Graves' Disease

Start date: October 15, 2018
Phase:
Study type: Observational [Patient Registry]

Graves' disease (GD) is one of organ specific autoimmune diseases, the pathogenesis is not elucidated.Natural Killer (Natural Killer, NK) cells is a kind of important immune regulator, several abnormalities of NK cell function and number in GD patients have been described in the investigators' previous study. It is remain unclear whether the NK cell disfunction is a consequence of GD.Based on the investigators' previous study, the investigators plan to monitor NK cell function in participants in the whole course of disease, analyze the association with relevant factors, such as thyroid function, immune state or treatment,to find out influences of thyroid hormones and thyroid receptor antibody affecting the function of NK cell. The investigators will reveal whether the disfunction of NK cell secondary to GD abnormal thyroid function and/or immune disorders, and realize the mechanics.